News MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Market Closed - Canadian Securities Exchange Other stock markets 14:46:11 2024-06-28 EDT			5-day change	1st Jan Change
0.05 ^CAD	+25.00%		+25.00%	+25.00%

03-21	MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	CI
03-04	MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	03-20	CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	03-04	CI
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director	01-30	CI
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.	01-30	NE
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO	12-06	CI
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman	12-06	CI
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer	12-06	CI
MYND Life Sciences Inc. Appoints John Campbell as President	12-06	CI
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer	12-05	NE
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences	12-04	NE
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.	23-10-25	NE
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.	23-10-24	CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	23-09-19	CI
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	23-06-28	CI
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	23-05-05	CI
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	23-04-27	CI
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	23-04-27	CI
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	22-09-27	CI
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	22-06-28	CI
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	22-06-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News MYND Life Sciences Inc.

Equities

MYND

CA62857B1094

Summary

Filters